Patricia Severino

Dr. Patricia Severino

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
JFJulia C. Fontoura
Julia C. Fontoura
CVChristian Viezzer
Christian Viezzer
FSFabiana G. dos Santos
Fabiana G. dos Santos
RLRosane A. Ligabue
Rosane A. Ligabue
RWRicardo Weinlich
Ricardo Weinlich
CBCristina Bonorino
Cristina Bonorino

12 February 2012 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
TSTatiana Taís Sibov
Tatiana Taís Sibov
PSPatricia Severino
Patricia Severino
LMLuciana Marti
Luciana Marti
LPL. F. Pavon
L. F. Pavon
DOD. M. Oliveira
D. M. Oliveira
CMC. A. Moreira-Filho
C. A. Moreira-Filho

9 November 2013 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PSPatricia Severino
Patricia Severino
HBHolger Bruggemann
Holger Bruggemann
FAFlavia Maziero Andreghetto
Flavia Maziero Andreghetto
CCCarme Camps
Carme Camps
MKMaria Klingbeil
Maria Klingbeil
ETEloiza Tajara
Eloiza Tajara
Current evidence implicates aberrant microRNA expression patterns in human malignancies; measurement of microRNA expression may have diagnostic and prognostic applications. Roles for microRNAs in head and neck squamous cell carcinomas (HNSCC) are largely unknown. HNSCC, a smoking-related cancer, is one of the most common malignancies worldwide but reliable diagnostic and prognostic markers have not been discovered so far. Some studies have evaluated the potential use of microRNA as biomarkers with clinical application in HNSCC.

26 May 2015 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
ASAdriana Sondermann
Adriana Sondermann
FAFlavia Maziero Andreghetto
Flavia Maziero Andreghetto
AMAna Carolina Bernardini Moulatlet
Ana Carolina Bernardini Moulatlet
EVElivane da Silva Victor
Elivane da Silva Victor
MCMarilia Germanos de Castro
Marilia Germanos de Castro
PSPatricia Severino
Patricia Severino

1 October 2007 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PSPatricia Severino
Patricia Severino
ODOlivier Dussurget
Olivier Dussurget
RVRicardo Z. N. Vêncio
Ricardo Z. N. Vêncio
EDEmilie Dumas
Emilie Dumas
PGPatricia Garrido
Patricia Garrido
CBCarmen Buchrieser
Carmen Buchrieser
Listeria monocytogenes is a food-borne, opportunistic, bacterial pathogen causing a wide spectrum of diseases, including meningitis, septicemia, abortion, and gastroenteritis, in humans and animals. Among the 13 L. monocytogenes serovars described, human listeriosis is mostly associated with strains of serovars 4b, 1/2b, and 1/2a. Within the species L. monocytogenes , three phylogenetic lineages are described. Serovar 1/2a belongs to phylogenetic lineage I, while serovars 4b and 1/2b group in phylogenetic lineage II. To explore the role of gene expression in the adaptation of L. monocytogenes strains of these two major lineages to different environments, as well as in virulence, we performed whole-genome expression profiling of six L. monocytogenes isolates of serovars 4b, 1/2b, and 1/2a of distinct origins, using a newly constructed Listeria multigenome DNA array. Comparison of the global gene expression profiles revealed differences among strains. The expression profiles of two strains having distinct 50% lethal doses, as assessed in the mouse model, were further analyzed. Gene ontology term enrichment analysis of the differentially expressed genes identified differences in protein-, nucleic acid-, carbon metabolism-, and virulence-related gene expression. Comparison of the expression profiles of the core genomes of all strains revealed differences between the two lineages with respect to cell wall synthesis, the stress-related sigma B regulon and virulence-related genes. These findings suggest different patterns of interaction with host cells and the environment, key factors for host colonization and survival in the environment.

11 November 2008 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
NSNelson José Freitas da Silveira
Nelson José Freitas da Silveira
LVLeonardo Varuzza
Leonardo Varuzza
AMAriane Machado-Lima
Ariane Machado-Lima
MLMarcelo de Souza Lauretto
Marcelo de Souza Lauretto
Daniel Guariz PinheiroDaniel Guariz Pinheiro
Daniel Guariz Pinheiro
ETEloiza Tajara
Eloiza Tajara
Background: Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignancies in humans. The average 5-year survival rate is one of the lowest among aggressive cancers, showing no significant improvement in recent years. When detected early, HNSCC has a good prognosis, but most patients present metastatic disease at the time of diagnosis, which significantly reduces survival rate. Despite extensive research, no molecular markers are currently available for diagnostic or prognostic purposes.Methods: Aiming to identify differentially-expressed genes involved in laryngeal squamous cell carcinoma (LSCC) development and progression, we generated individual Serial Analysis of Gene Expression (SAGE) libraries from a metastatic and non-metastatic larynx carcinoma, as well as from a normal larynx mucosa sample. Approximately 54,000 unique tags were sequenced in three libraries.Results: Statistical data analysis identified a subset of 1,216 differentially expressed tags between tumor and normal libraries, and 894 differentially expressed tags between metastatic and non-metastatic carcinomas. Three genes displaying differential regulation, one down-regulated (KRT31) and two up-regulated (BST2,MFAP2), as well as one with a non-significant differential expression pattern (GNA15) in our SAGE data were selected for real-time polymerase chain reaction (PCR) in a set of HNSCC samples. Consistent with our statistical analysis, quantitative PCR confirmed the upregulation ofBST2andMFAP2and the downregulation ofKRT31when samples of HNSCC were compared to tumor-free surgical margins. As expected,GNA15presented a non-significant differential expression pattern when tumor samples were compared to normal tissues.Conclusion: To the best of our knowledge, this is the first study reporting SAGE data in head and neck squamous cell tumors. Statistical analysis was effective in identifying differentially expressed genes reportedly involved in cancer development. The differential expression of a subset of genes was confirmed in additional larynx carcinoma samples and in carcinomas from a distinct head and neck subsite. This result suggests the existence of potential common biomarkers for prognosis and targeted-therapy development in this heterogeneous type of tumor.